Showing 1 - 20 results of 38 for search 'Lorenzo Giovanni Mantovani', query time: 0.07s
Refine Results
-
1
The Importance of Real-World Evidence in Understanding Influenza Vaccine Effectiveness by Pietro Ferrara, Lorenzo Giovanni Mantovani
Published 2022-03-01
Article -
2
-
3
Cost-utility analysis of abatacept in rheumatoid arthritis in Italy by Simona de Portu, Lorenzo Giovanni Mantovani, Ignazio Olivieri
Published 2008-03-01
Article -
4
-
5
-
6
-
7
-
8
Letter to the editor: Clinical Use, Quality of Life and Cost-Effectiveness of Spinal Cord Stimulation Used to Treat Patients with Failed Back Surgery Syndrome by Luciana Scalone, Lorenzo Giovanni Mantovani, Angelo Lavano, Amedeo Costantini, Gianpaolo Fortini, Furio Zucco
Published 2017-08-01
Article -
9
Time-Varying Effect of Hybrid Immunity on the Risk of Breakthrough Infection after Booster Dose of mRNA COVID-19 Vaccine: The MOSAICO Study by Pietro Ferrara, Domenico Ponticelli, Roberto Magliuolo, Mario Borrelli, Beniamino Schiavone, Lorenzo Giovanni Mantovani
Published 2022-08-01
Article -
10
-
11
-
12
-
13
Cost-effectiveness and budget impact analysis of siponimod in the treatment of secondary progressive multiple sclerosis in Italy by Paolo Angelo Cortesi, Ippazio Cosimo Antonazzo, Claudio Gasperini, Mihaela Nica, Daniela Ritrovato, Lorenzo Giovanni Mantovani
Published 2022-01-01
Article -
14
Cost-Effectiveness Analysis of Dimethyl Fumarate in the Treatment of Relapsing Remitting Multiple Sclerosis: An Italian Societal Perspective by Lorenzo Giovanni Mantovani, Gianluca Furneri, Rossella Bitonti, Paolo Cortesi, Elisa Puma, Laura Santoni, Luca Prosperini
Published 2019-07-01
Article -
15
Cost-effectiveness and budget impact analysis of siponimod in the treatment of secondary progressive multiple sclerosis in Italy. by Paolo Angelo Cortesi, Ippazio Cosimo Antonazzo, Claudio Gasperini, Mihaela Nica, Daniela Ritrovato, Lorenzo Giovanni Mantovani
Published 2022-01-01
Article -
16
-
17
[Cost-effectiveness analysis of delayed-release dimethyl-fumarate in the treatment of relapsing-remitting multiple sclerosis in Italy] by Gianluca Furneri, Laura Santoni, Chiara Marchesi, Sergio Iannazzo, Paolo Angelo Cortesi, Achille Patrizio Caputi, Lorenzo Giovanni Mantovani
Published 2016-06-01
Article -
18
Critical Review of the Pivotal Studies of Four rFVIII Products for the Treatment of Hemophilia A Patients: The Role of Octocog Alfa by Matteo Nicola Dario Di Minno, Lucia D'Angiolella, Paolo Angelo Cortesi, Angelo Claudio Molinari, Lorenzo Giovanni Mantovani
Published 2020-04-01
Article -
19
-
20